Treatment strategies and LDL cholesterol target attainment in patients with statin intolerance: Insights from the multicentre statin intolerance registry

This publication has 25 references indexed in Scilit:

• Unique features of dyslipidemia in women across a lifetime and a tailored approach to management
  American Journal of Preventive Cardiology, 2024
• Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study
  Cardiovascular Drugs and Therapy, 2022
• National trends and disparities in statin use for ischemic heart disease from 2006 to 2018: Insights from National Ambulatory Medical Care Survey
  American Heart Journal, 2022
• Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)
  Journal of Cachexia, Sarcopenia and Muscle, 2022
• PEARL: A Non-interventional Study of Real-World Alirocumab Use in German Clinical Practice
  Drugs - Real World Outcomes, 2019
• Health-related quality of life measured with the EQ-5D-5L: estimation of normative index values based on a representative German population sample and value set
  The European Journal of Health Economics, 2019
• Lipid management in contemporary community practice: Results from the Provider Assessment of Lipid Management (PALM) Registry
  American Heart Journal, 2017
• The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability
  Cardiovascular Drugs and Therapy, 2017
• Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction
  JACC, 2017
• Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016)
  Canadian Journal of Cardiology, 2016